Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A R Hubbard

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Critical Care Medicine|February 15, 2001
Antithrombin inhibits lipopolysaccharide-induced tissue factor and interleukin-6 production by mononuclear cells, human umbilical vein endothelial cells, and whole bloodP J Souter, S Thomas, A R Hubbard, et al.
Journal of Thrombosis and Haemostasis : JTH|September 6, 2012
Long-term stability of the Scientific and Standardization Committee Secondary Coagulation Standard (SSC Lot no. 3)A R Hubbard, S Kitchen, M Beeharry, et al.
Journal of Thrombosis and Haemostasis : JTH|February 15, 2013
Recommendations on the potency labelling of factor VIII and factor IX concentratesA R Hubbard, J Dodt, T Lee, et al.
Thrombosis and Haemostasis|November 24, 1989
Procoagulant activity of T lymphoblastoid cells in extrinsic and intrinsic coagulation systemsT W Barrowcliffe, D E Marshall, L P Trickett, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 28, 2015
Potency determination of factor VIII and factor IX for new product labelling and postinfusion testing: challenges for caregivers and regulatorsJ Dodt, A R Hubbard, S J Wicks, et al.
Journal of Thrombosis and Haemostasis : JTH|July 15, 2010
International collaborative study for the calibration of a proposed international standard for thromboplastin, human, plainA Tripodi, V Chantarangkul, A M H P Van Den Besselaar, et al.
Journal of Thrombosis and Haemostasis : JTH|June 15, 2012
Standardization of von Willebrand factor propeptide: value assignment to the WHO 6th IS Factor VIII/von Willebrand factor, plasma (07/316)A R Hubbard, M Hamill, H C J Eikenboom, et al.
Thrombosis and Haemostasis|November 3, 1998
Modification of factor VIII in therapeutic concentrates after virus inactivation by solvent-detergent and pasteurisationS Raut, M Di Giambattista, S A Bevan, et al.
Thrombosis and Haemostasis|October 30, 1985
Standardization of low molecular weight heparins: a collaborative studyT W Barrowcliffe, A D Curtis, T P Tomlinson, et al.
Thrombosis Research|December 15, 1986
Assay of factor VIII concentrates: comparison of the chromogenic and two-stage clotting assaysA R Hubbard, A D Curtis, T W Barrowcliffe, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Critical Care Medicine|February 15, 2001
Antithrombin inhibits lipopolysaccharide-induced tissue factor and interleukin-6 production by mononuclear cells, human umbilical vein endothelial cells, and whole bloodP J Souter, S Thomas, A R Hubbard, et al.
Journal of Thrombosis and Haemostasis : JTH|September 6, 2012
Long-term stability of the Scientific and Standardization Committee Secondary Coagulation Standard (SSC Lot no. 3)A R Hubbard, S Kitchen, M Beeharry, et al.
Journal of Thrombosis and Haemostasis : JTH|February 15, 2013
Recommendations on the potency labelling of factor VIII and factor IX concentratesA R Hubbard, J Dodt, T Lee, et al.
Thrombosis and Haemostasis|November 24, 1989
Procoagulant activity of T lymphoblastoid cells in extrinsic and intrinsic coagulation systemsT W Barrowcliffe, D E Marshall, L P Trickett, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 28, 2015
Potency determination of factor VIII and factor IX for new product labelling and postinfusion testing: challenges for caregivers and regulatorsJ Dodt, A R Hubbard, S J Wicks, et al.
Journal of Thrombosis and Haemostasis : JTH|July 15, 2010
International collaborative study for the calibration of a proposed international standard for thromboplastin, human, plainA Tripodi, V Chantarangkul, A M H P Van Den Besselaar, et al.
Journal of Thrombosis and Haemostasis : JTH|June 15, 2012
Standardization of von Willebrand factor propeptide: value assignment to the WHO 6th IS Factor VIII/von Willebrand factor, plasma (07/316)A R Hubbard, M Hamill, H C J Eikenboom, et al.
Thrombosis and Haemostasis|November 3, 1998
Modification of factor VIII in therapeutic concentrates after virus inactivation by solvent-detergent and pasteurisationS Raut, M Di Giambattista, S A Bevan, et al.
Thrombosis and Haemostasis|October 30, 1985
Standardization of low molecular weight heparins: a collaborative studyT W Barrowcliffe, A D Curtis, T P Tomlinson, et al.
Thrombosis Research|December 15, 1986
Assay of factor VIII concentrates: comparison of the chromogenic and two-stage clotting assaysA R Hubbard, A D Curtis, T W Barrowcliffe, et al.
Pageof 6